Fein, Francine <br/><br/>
The prognosis of patients having received optimal therapy for nonvariceal upper gastrointestinal bleeding might be worse in daily practice than in randomized clinical trials.  [electronic resource] 

 -  European journal of gastroenterology & hepatology  Mar 2010 
 - 361-7 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1473-5687 
<br/><br/><label>Standard No.: </label>10.1097/meg.0b013e32832ad8dc  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>2-Pyridinylmethylsulfinylbenzimidazoles--administration & dosage<br/>Administration, Oral<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Chi-Square Distribution<br/>Combined Modality Therapy<br/>Female<br/>France--epidemiology<br/>Hemostasis, Endoscopic--adverse effects<br/>Hospital Mortality<br/>Hospitals, University<br/>Humans<br/>Infusions, Intravenous<br/>Injections, Intravenous<br/>Intensive Care Units<br/>Logistic Models<br/>Male<br/>Middle Aged<br/>Odds Ratio<br/>Pantoprazole<br/>Peptic Ulcer Hemorrhage--mortality<br/>Proton Pump Inhibitors--administration & dosage<br/>Randomized Controlled Trials as Topic<br/>Recurrence<br/>Retrospective Studies<br/>Risk Assessment<br/>Risk Factors<br/>Treatment Outcome<br/>Young Adult